DLBCL with MYC and BCL6 rearrangements is currently included as a genetic subtype under DLBCL, NOS, in WHO-HAEM5,(32) in contrast to WHO-HAEM4R(33) and ICC.(2). Here, MYC is linked to intrahepatic cholangiocarcinoma.